Case number 1:21-cv-00229
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 16, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Corrected document (further redacted) added to D.I. 493 in 20md2930, D.I. 386 in 19-1979, D.I. 122 in 20-415, and D.I. 40 in 21-229 per request of counsel. Associated Cases: 1:20-md-02930-LPS, 1:19-cv-01979-LPS, 1:20-cv-00415-LPS, 1:21-cv-00229-LPS (ntl) |
| Feb 14, 2022 | 40 | Redacted Document (5) Docket Text: REDACTED VERSION of (119 in 1:20-cv-00415-LPS, 376 in 1:19-cv-01979-LPS, 481 in 1:20-md-02930-LPS, 39 in 1:21-cv-00229-LPS) Stipulation by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Main Document 40 replaced on 2/16/2022) (ntl). |
| Feb 9, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [39] Stipulation of Dismissal filed by Novartis Pharmaceuticals Corporation, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 2/8/22. (ntl) |
| Dec 15, 2021 | 38 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of Opening Expert Reports filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Dec 9, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Whitney M. Howard for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Dec 1, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher E. Loh for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Nov 30, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Laura K. Fishwick, Christina Schwarz, and Nicholas N. Kallas for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Nov 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (424 in 1:20-md-02930-LPS, 37 in 1:21-cv-00229-LPS) MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, Susanne L. Flanders, Jared L. Stringham, Laura K. Fishwick, Gregory J. Manas, and Whitney Meier Howard filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 11/30/21. Associated Cases: 1:21-cv-00229-LPS, 1:20-md-02930-LPS (ntl) |
| Nov 19, 2021 | 37 | Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, S (8) |
| Nov 19, 2021 | 37 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, Susanne L. Flanders, Jared L. Stringham, Laura K. Fishwick, Gregory J. Manas, and Whitney Meier Howard - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, Susanne L. Flanders, Jared L. Stringham, Laura K. Fishwick, Gregory J. Manas, and Whitney Meier Howard)(Silver, Daniel) |
| Nov 16, 2021 | 36 | Redacted Document (17) Docket Text: REDACTED VERSION of (196 in 1:19-cv-02053-LPS, 114 in 1:20-cv-00415-LPS, 339 in 1:19-cv-01979-LPS, 132 in 1:19-cv-02021-LPS, 35 in 1:21-cv-00229-LPS, 106 in 1:20-cv-00074-LPS, 157 in 1:20-cv-00445-LPS, 407 in 1:20-md-02930-LPS) Status Report by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Nov 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (336 in 1:19-cv-01979-LPS, 104 in 1:20-cv-00074-LPS, 404 in 1:20-md-02930-LPS, 194 in 1:19-cv-02053-LPS, 130 in 1:19-cv-02021-LPS, 155 in 1:20-cv-00445-LPS, 112 in 1:20-cv-00415-LPS, 34 in 1:21-cv-00229-LPS) STIPULATION TO EXTEND TIME the Deadline for the Submissionof the Joint Status Report to November 8, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 11/4/21. Associated Cases: 1:19-cv-01979-LPS et al. (ntl) |
| Nov 3, 2021 | 34 | Stipulation to EXTEND Time (12) Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Submissionof the Joint Status Report to November 8, 2021 - filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Sep 17, 2021 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Lupin Atlantis Holdings, S.A., Lupin Limited, Lupin Inc., and Lupin Pharmaceuticals, Inc.'s First Set of Interrogatories (Nos. 1-3) filed by Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Sep 9, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Carol M. Pitzel Cruz for Lupin Atlantis Holdings, S.A., Lupin Inc.,Lupin Limited, and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Aug 31, 2021 | 32 | Notice of Service (20) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's First Supplemental Infringement Contentions Against Defendants, and (2) Novartis's First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories (Nos. 1-3) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Aug 4, 2021 | 31 | Redacted Document (17) Docket Text: REDACTED VERSION of [30] Answer to Counterclaim by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Jul 29, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrea L. Cheek for Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jul 26, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys William R. Zimmerman and Catherine R. Gourash for Lupin Atlantis Holdings, Lupin Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Jul 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [29] MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrea L. Cheek, Catherine R. Gourash, and Carol Pitzel Cruz filed by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 7/23/21. (ntl) |
| Jul 22, 2021 | 29 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrea L. Cheek, Catherine R. Gourash, and Carol Pitzel Cruz - filed by Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) |
| Jul 14, 2021 | 28 | Redacted Document (30) Docket Text: REDACTED VERSION of [27] Answer to Complaint,, Counterclaim, by Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) |
| Jun 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (253 in 1:19-cv-01979-LPS, 25 in 1:21-cv-00229-LPS, 81 in 1:20-cv-00415-LPS, 279 in 1:20-md-02930-LPS) STIPULATION TO EXTEND TIME to answer the Amended Complaint to July 7, 2021 filed by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 6/29/21. Associated Cases: 1:19-cv-01979-LPS, 1:20-cv-00415-LPS, 1:20-md-02930-LPS, 1:21-cv-00229-LPS (ntl) |
| Jun 24, 2021 | 26 | Redacted Document (7) Docket Text: REDACTED VERSION of (24 in 1:21-cv-00229-LPS, 276 in 1:20-md-02930-LPS, 80 in 1:20-cv-00415-LPS, 250 in 1:19-cv-01979-LPS) Stipulation of Dismissal by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Jun 22, 2021 | 25 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to answer the Amended Complaint to July 7, 2021 - filed by Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) |
| Jun 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (24 in 1:21-cv-00229-LPS, 276 in 1:20-md-02930-LPS, 80 in 1:20-cv-00415-LPS, 250 in 1:19-cv-01979-LPS) Stipulation and Order Dismissing Certain Claims filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 6/21/21. Associated Cases: 1:19-cv-01979-LPS, 1:20-cv-00415-LPS, 1:20-md-02930-LPS, 1:21-cv-00229-LPS (ntl) |
| Jun 18, 2021 | 23 | Transcript (115) Docket Text: Official Transcript of Claim Construction Hearing held on June 8, 2021 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/9/2021. Redacted Transcript Deadline set for 7/19/2021. Release of Transcript Restriction set for 9/16/2021. (bpg) |
| Jun 9, 2021 | 22 | Amended Complaint* (1) |
| Jun 9, 2021 | 22 | Exhibit A-D (67) |
| Jun 9, 2021 | 22 | Main Document (31) Docket Text: AMENDED COMPLAINT against Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.- filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D)(Silver, Daniel) |
| Jun 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (250 in 1:20-md-02930-LPS, 85 in 1:19-cv-02021-LPS, 66 in 1:20-cv-00415-LPS, 236 in 1:19-cv-01979-LPS, 13 in 1:21-cv-00229-LPS, 115 in 1:20-cv-00445-LPS, 63 in 1:20-cv-00074-LPS, 133 in 1:19-cv-02053-LPS) STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's Amended Complaints. Signed by Judge Leonard P. Stark on 6/9/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Jun 8, 2021 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing (by remote video) held on 6/8/2021. (Court Reporter B. Gaffigan.) Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| Jun 7, 2021 | 21 | Main Document (3) Docket Text: Letter to Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Dispute Letter - re (261 in 1:20-md-02930-LPS) Order,,. (Attachments: # (1) Exhibit A)(Silver, Daniel) |
| Jun 7, 2021 | 21 | Exhibit A (38) |
| Jun 3, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman hearing on June 8, 2021 at 10:00 a.m. is available to the public using the following dial-in for audio access: +1 646 828 7666 US -- Meeting ID: 161 238 3790 -- Passcode: 824345 -- One Tap Mobile Public Dial-In Number: +16468287666,,1612383790#,,,,*824345# US. Audio reproduction of the proceeding is strictly prohibited. ORDERED by Judge Leonard P. Stark on 6/3/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| May 25, 2021 | 19 | Main Document (2) Docket Text: Letter to Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Claim Construction Hearing. (Attachments: # (1) Exhibit 58)(Silver, Daniel) |
| May 25, 2021 | 19 | Exhibit 58 (13) |
| May 24, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' letter concerning the claim construction hearing scheduled for June 8 at 10:00 a.m. (C.A. No. 20-md-2930 D.I. 256), IT IS HEREBY ORDERED that each side will be allocated 75 minutes for its presentation. The hearing will be conducted by videoconference technology. Defendants shall submit access information for the Court, including access information for any interested member of the public, in advance of the hearing. The parties may present argument in the order they propose in the letter. IT IS FURTHER ORDERED that each party shall submit any slides or other materials to be referenced at the hearing by no later than June 7 at 4:00 p.m. ORDERED by Judge Leonard P. Stark on 5/24/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| May 21, 2021 | 17 | Letter (2) Docket Text: Letter to The Honorable Chief Judge Leonard P. Stark from Daniel M. Silver, Esq. regarding Claim Construction Hearing. (Silver, Daniel) |
| May 21, 2021 | 16 | Exhibit 45-57 (180) |
| May 21, 2021 | 16 | Exhibit 44 (54) |
| May 21, 2021 | 16 | Exhibit 35-43 (83) |
| May 21, 2021 | 16 | Exhibit 1-29 (200) |
| May 21, 2021 | 16 | Main Document (16) Docket Text: APPENDIX re (14 in 1:21-cv-00229-LPS) Joint Claim Construction Brief, (88 in 1:19-cv-02021-LPS) Joint Claim Construction Brief, (69 in 1:20-cv-00415-LPS) Joint Claim Construction Brief, (118 in 1:20-cv-00445-LPS) Joint Claim Construction Brief, (136 in 1:19-cv-02053-LPS) Joint Claim Construction Brief, (253 in 1:20-md-02930-LPS) Joint Claim Construction Brief, (239 in 1:19-cv-01979-LPS) Joint Claim Construction Brief, (66 in 1:20-cv-00074-LPS) Joint Claim Construction Brief (Volume 2 -- Exhibits 1-57) by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1-29, # (2) Exhibit 35-43, # (3) Exhibit 44, # (4) Exhibit 45-57)(Silver, Daniel) |
| May 21, 2021 | 15 | Exhibit A-D (431) |
| May 21, 2021 | 15 | Main Document (16) Docket Text: APPENDIX re (14 in 1:21-cv-00229-LPS) Joint Claim Construction Brief, (88 in 1:19-cv-02021-LPS) Joint Claim Construction Brief, (69 in 1:20-cv-00415-LPS) Joint Claim Construction Brief, (118 in 1:20-cv-00445-LPS) Joint Claim Construction Brief, (136 in 1:19-cv-02053-LPS) Joint Claim Construction Brief, (253 in 1:20-md-02930-LPS) Joint Claim Construction Brief, (239 in 1:19-cv-01979-LPS) Joint Claim Construction Brief, (66 in 1:20-cv-00074-LPS) Joint Claim Construction Brief (Volume 1 -- Exhibits A-D) by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D)(Silver, Daniel) |
| May 21, 2021 | 14 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| May 18, 2021 | 13 | Exhibit A-N (614) |
| May 18, 2021 | 13 | Main Document (13) Docket Text: STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's Amended Complaints by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-N)(Silver, Daniel) |
| May 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (82 in 1:19-cv-02021-LPS, 60 in 1:20-cv-00074-LPS, 112 in 1:20-cv-00445-LPS, 247 in 1:20-md-02930-LPS, 233 in 1:19-cv-01979-LPS, 63 in 1:20-cv-00415-LPS, 12 in 1:21-cv-00229-LPS, 130 in 1:19-cv-02053-LPS) STIPULATION TO EXTEND TIME for Paintiff to Amend or Supplement Pleadings to May 18, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 5/17/21. Associated Cases: 1:20-md-02930-LPS et al. (ntl) |
| May 14, 2021 | 12 | Stipulation to EXTEND Time (13) Docket Text: STIPULATION TO EXTEND TIME Deadline for Paintiff to Amend or Supplement Pleadings to May 18, 2021 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| May 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] STIPULATION TO EXTEND TIME to Answer Complaint to June 10, 2021 filed by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 5/10/21. (ntl) |
| May 7, 2021 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to June 10, 2021 - filed by Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) |
| Apr 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to Answer Complaint to May 10, 2021 filed by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/23/21. (ntl) |
| Apr 22, 2021 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to May 10, 2021 - filed by Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) |
| Mar 1, 2021 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Pharmaceuticals, Inc. waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Mar 1, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Limited waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Mar 1, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Inc. waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Mar 1, 2021 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Atlantis Holdings, S.A. waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Feb 24, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Feb 18, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (apk) |
| Feb 18, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (apk) |
| Feb 18, 2021 | 4 | ANDA Form (3) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/5/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 7/7/2023. (apk) |
| Feb 18, 2021 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659 ;8,796,331 ;8,877,938 ;9,388,134. (apk) |
| Feb 18, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Feb 18, 2021 | 1 | Civil Cover Sheet (2) |
| Feb 18, 2021 | 1 | Exhibit A-D (67) |
| Feb 18, 2021 | 1 | Main Document (28) Docket Text: COMPLAINT filed against Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3530964.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(apk) |
| Feb 18, 2021 | 1 | Complaint* (1) |
